Loading chart...
ABBVABBV
$285.78Up 0.21 percent, +$0.59
As of today at 2:21 PM ET
Key Stats
Market Cap$503.275B
Volume (24h)2,374,687
Day's Range$282.41-$286.57
52-Week Range$190.75-$291.40
PE Ratio140.09
EPS2.04
Net Income (FY)$4.23B
Revenue (FY)$61.16B
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
- Website
- abbvie.com
- Industry
- PHARMACEUTICAL PREPARATIONS
- Full-time Employees
- 57,000
- Headquarters
- NORTH CHICAGO
- IPO Date
- Dec 10, 2012
| 24 hours | 5 days | 1 month | YTD | 1 year | All time |
|---|---|---|---|---|---|
Up 0.21 percent | Up 0.13 percent | Up 7.75 percent | Up 24.39 percent | Up 24.97 percent | Up 713.72 percent |
